New study summarizes human surveillance data from 2011-2018 in the United States for Babesia infections reported to the Centers for Disease Control and Prevention (CDC) through the National Notifiable Diseases Surveillance System (NNDSS). Data shows an increasing trend of reported Babesia cases (14,159 total) during this time period, with white men in the middle and […]
This section contains information on legislation that has been introduced and/or passed by the federal government. It includes sections that contain the position the Lyme Disease Association (LDA) has taken on various bills, if any, and information on how to contact your legislator; and what you can do to help specific laws be passed or defeated. Additionally, there is a section on various government departments. From time to time, the LDA will post articles from the departments/agencies in these sections that pertain to Lyme disease that might be of interest or importance to the public, including policies being considered or adopted.
It is important for the LDA to take a lead role in forming relationships with all levels of government. Laws and policy decisions often affect how Lyme disease is viewed by the public and physicians, and LDA needs to clearly articulate the problems which are created by government actions or which can be rectified by government actions. Additionally, we need to ensure that the information presented to government officials is accurate and supported by science.
The section contains articles of individual state activities and multi state activities related to government actions or patients’ or advocates’ action to legislate or educate. Click on the picture of your state or click on USA for multistate actions or information. A-USA California Colorado Connecticut Delaware Florida Georgia Illinois Kansas Maine Maryland Massachusetts Minnesota […]
The Congressional Lyme Disease Caucus is a bi-partisan group working together in the U.S. House of Representatives to take action on Lyme & tick-borne diseases. Under the continued leadership of Congressmen Chris Smith (NJ) and now with the new 2021 co-chair, Henry Cuellar (TX), the Caucus will help the Lyme Community by focusing on Lyme […]
Tick submissions needed! The Missouri Department of Conservation (MDC) and A.T. Still University are partnering on a Missouri tick study. MDC and the University are asking for citizens of Missouri to collect, save, and mail ticks that they encounter to A.T. Still University to assist with this study.
“one little bite” is a video short that was produced by Monica White, COTBDAA Co-founder/President, in a storytelling workshop hosted by Chaffee County Public Health. This is a story about one person, one family, whose lives were forever changed by the bite of a tick. Though presentation of this story may be unique, the theme […]
Our companion animals get Lyme disease too. Here are several PSAs from veterinarians
in Vermont reminding pet owners to be aware of the problems pets face from Lyme disease. The Lyme Disease Association Inc. also reminds you that pets can bring unattached ticks into the home which can then bite humans.
Congress recently increased annual funding for research on Lyme and related tickborne diseases at NIH by $29 million to a total of $63 million. Most of this is discretionary, although $10 million of it is mandatory for research specific to Lyme disease. In addition to this historic increase, there are opportunities for funding and research support for studies on maternal-fetal transmission of Lyme disease and the impact of pregnancy on immune response. To stimulate researcher interest, NIH has issued a series of notices to encourage investigators to apply for grants and has asked stakeholder organizations for help getting the word out.
The FY21 Tick-Borne Disease Research Program (TBDRP) Program Announcements managed by the Department of Defense (DOD) office of Congressionally Directed Medical Research Programs (CDMRP) are now posted to the grants.gov (search grants by CFDA Number 12.420) and on the CDMRP website.
Pfizer has received priority review for their vaccine, TicoVac, that protects against tick-borne encephalitis. This tick-borne virus can cause meningitis and trigger long-term neurological symptoms. If approved, the vaccine would potentially protect travelers as well as members of the US military that are deployed to regions where the virus is common, such as Europe and parts of Asia.
STATE LEGISLATION IN THE LYMELIGHT By: Pat Smith, President, Lyme Disease Association, Inc. Lorraine Johnson, Executive Director, California Lyme Disease Association Passing legislation to combat problems associated with Lyme disease can help correct some of the problems Lyme patients face, or it can exacerbate the very problems that it is intended to address. This […]